---
DrugClass: "[[Immune Blockers]]"
SubClass: "[[Monoclonal antibodies]]"
DrugClassAdverse: "[[Monoclonal antibodies#Adverse Reactions]]"
DrugClassContra: "[[Monoclonal antibodies#Contraindications]]"
BrandName: Otezla
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "49"
KindleLinkChap: "[Chapter 49](kindle://book?action=open&asin=B09FRF11YJ&location=28643)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: Psoriasis
---
```smiles
CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Psoriasis, PA, oral ulcers of [[Behcet disease]]
10–20 mg daily or twice daily

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Nasopharyngitis, nausea, diarrhea, weight loss

### Interactions

`= this.ChemLink+this.file.name`

